You are here: Industry Insights > Bayer

News List

Bayer Invests $150M to Build Cell Culture Technology Center contractpharma
May 10, 2019
Bayer is investing $150 million in its Berkeley, CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center for the development of biological therapies.
Bayer's Q1 sales boosted by performance of Xarelto, Eylea, while profit held back by acquisition, restructuring costs firstwordpharma
April 26, 2019
CEO Werner Baumann noted that the pharmaceutical division "delivered encouraging performance."
Bayer invests in Khloris’ anti-cancer vaccines programme pharmaceutical-technology
April 23, 2019
Bayer invests in Khloris’ anti-cancer vaccines programme.
Darolutamide NDA to treat non-metastatic castration-resistant prostate cancer europeanpharmaceuticalreview
April 12, 2019
A New Drug Application has been made to the US Food and Drug Administration for the drug darolutamide to treat non-metastatic prostate cancer…
ProteoNic Biotechnology Licenses Protein Production Technology to Bayer b3cnewswire
April 09, 2019
ProteoNic Biotechnology Licenses Protein Production Technology to Bayer
Leaps by Bayer, Khloris to develop breakthrough anti-cancer vaccines biospectrumasia
April 03, 2019
Leaps by Bayer, the investment arm of the global life sciences company Bayer, and Khloris Biosciences, a biotechnology company……
AACR: Bayer posts early clinical data on follow-up to Loxo's Vitrakvi fiercebiotech
April 03, 2019
Bayer has shared preliminary clinical data on the second TRK inhibitor it licensed from Loxo Oncology.
Bayer, Johnson & Johnson to pay $775 million to settle US litigation related to Xarelto firstwordpharma
March 26, 2019
Bayer announced Monday that along with partner Johnson & Johnson, the companies have reached a deal in principle to pay $775 million to ……
Bayer reaches settlement to resolve Xarelto™ litigation worldpharmanews
March 26, 2019
More than five years after the Xarelto™ litigation began, and with Bayer and Janssen Pharmaceuticals prevailing in all six cases that went to trial, the companies have reached an agreement in principle to settle in the amount of 775 million U.S. dollars.
Bayer animal health sale can rake in $8B and bids from private equity fiercepharma
March 21, 2019
AbbVie and Roche are looking to move key oncology drug Venclexta deeper into the blood cancer arena, but their ambitions in multiple myeloma just took a hit.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page